ISRA - ETF AI Analysis
Top Page
VanEck Israel ETF (ISRA)
ISRA, the VanEck Israel ETF, earns a solid overall rating thanks to several strong Israeli financial and technology holdings, especially leading banks like Bank Leumi, Poalim, and Mizrahi Tefahot, which combine strong financial performance with generally favorable valuations and momentum. Major tech names such as Palo Alto Networks, Tower Semiconductor, and Check Point also support the fund’s quality through growth and positive earnings trends, though their higher valuations and some bearish technical signals, along with profitability and leverage concerns at companies like Teva and JFrog, introduce risk. The main risk factor is the ETF’s concentration in a single country (Israel), which can make the fund more sensitive to local economic and market conditions.
ISRA vs. SPDR S&P 500 ETF (SPY)
- AUM
- 151.84M
- Region
- Middle East & Africa
- Expense Ratio
- 0.59%
- Beta
- 0.79
- Issuer
- VanEck
- Inception Date
- Jun 25, 2013
- Dividend Yield
- 1.38%
- Asset Class
- Equity
- Index Tracked
- BlueStar Israel Global Index
ISRA Summary
The VanEck Israel ETF (ISRA) follows the BlueStar Israel Global Index and gives you broad exposure to Israeli companies, from fast-growing tech firms to banks and healthcare businesses. It holds well-known names like Palo Alto Networks and Teva, so you’re investing in both innovation and more established industries. Someone might choose this ETF to diversify beyond the U.S. market and tap into Israel’s reputation as a “Start-Up Nation” with potential for long-term growth. A key risk is that it’s focused on one country and is heavily tilted toward technology, so its price can move sharply with market and regional news.
How much will it cost me?
This ETF has an expense ratio of 0.59%, which means you’ll pay about $5.90 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because it targets a more specialized market (Israeli stocks), which typically costs more to manage than broad, plain-vanilla index funds.
What would affect this ETF?
This Israel-focused ETF could benefit if global demand for technology, cybersecurity, and innovative healthcare solutions grows, since it is heavily invested in Israeli tech companies and major local banks that may gain from a stable or improving economy and supportive interest-rate trends. On the other hand, it could be hurt by regional geopolitical tensions, stricter regulations on technology or financial firms, weaker global growth, or rising interest rates that pressure both high-growth tech stocks and Israel’s broader market.
ISRA Top 10 Holdings
ISRA leans heavily into Israel’s tech and cybersecurity story, with Palo Alto Networks and Check Point acting as key engines of performance—both have been rising over the past few months, even if Check Point’s year has been more mixed. Tower Semiconductor and JFrog add more tech firepower, though their strong momentum comes with valuation and profitability questions that can inject volatility. On the steadier side, Teva and big banks like Leumi and Poalim help anchor the fund, but recent softness in financials has slightly weighed on returns. Overall, this is a concentrated bet on Israeli innovation, almost entirely tied to the local market.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 PANW | Palo Alto Networks | 13.82% | $20.93M | $299.56B | 59.70% | 73Outperform |
 IL:TEVA | Teva | 8.67% | $13.13M | ILS 149.16B | 96.19% | 61Neutral |
 IL:LUMI | Leumi | 5.53% | $8.37M | ILS 105.71B | 14.46% | 80Outperform |
 IL:POLI | Poalim | 4.93% | $7.47M | ILS 94.98B | 13.69% | 79Outperform |
 IL:ESLT | Elbit Systems | 4.32% | $6.54M | ILS 114.84B | 54.08% | 73Outperform |
 TSEM | Tower | 2.86% | $4.34M | $18.90B | 82.36% | 76Outperform |
 FROG | JFrog | 2.37% | $3.59M | $11.64B | 79.25% | 73Outperform |
 CHKP | Check Point | 2.28% | $3.46M | $15.53B | -27.69% | 76Outperform |
 IL:PHOE | Phoenix | 2.17% | $3.28M | ILS 42.92B | 37.40% | 79Outperform |
 IL:MZTF | Mizrahi Tefahot | 2.17% | $3.28M | ILS 57.46B | 9.28% | 80Outperform |
ISRA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ISRA, the sentiment is Negative. The current price of 62.75 is below the 20-day moving average (MA) of 65.67, below the 50-day MA of 66.54, and below the 200-day MA of 65.27, indicating a bearish trend. The MACD of -0.47 indicates Positive momentum. The RSI at 35.28 is Neutral, neither overbought nor oversold. The STOCH value of 11.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ISRA.
ISRA Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| ISRA | $62.75 | $72.00(14.73% Upside) | $151.84M | 0.59% | 68Neutral |
 JHMD | $44.37 | $52.75(18.88% Upside) | $995.29M | 0.39% | 64Neutral |
 GSID | $74.58 | $89.68(20.25% Upside) | $1.01B | 0.20% | 66Neutral |
 HLAL | $70.44 | $93.09(32.15% Upside) | $972.36M | 0.50% | 76Outperform |
 SEUS | $25.63 | $31.01(21.00% Upside) | $934.57M | 0.30% | 73Outperform |
 ISRL | $22.48 | ― | $1.17M | 0.59% | 58Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ISRA | VanEck Israel ETF | 62.75 | 8.76 | 16.23% | |
| JHMD | John Hancock Multifactor Developed International ETF | 44.37 | 5.69 | 14.71% | |
| GSID | Goldman Sachs MarketBeta International Equity ETF | 74.58 | 9.61 | 14.80% | |
| HLAL | Wahed FTSE USA Shariah ETF | 70.44 | 9.97 | 16.48% | |
| SEUS | SEI QiM U.S. Equity Factor Allocation Active ETF | 25.63 | 0.36 | 1.44% | |
| ISRL | Defiance KSM Israel 120 ETF | 22.48 | -2.19 | -8.89% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.